Skip to main content
. 2020 Aug 17;39:162. doi: 10.1186/s13046-020-01662-3

Table 1.

Co-occurrence analysis of Mucins in lung cancer

Cancer A B Neither A Not B B Not A Both Log2 Odds Ratio p-Value q-Value Tendency
LUAD MUC2 MUC16 404 21 265 38 1.464 < 0.001 0.003 Co-occurrence
MUC3A MUC16 421 4 284 19 2.816 < 0.001 < 0.001 Co-occurrence
MUC5B MUC16 395 30 244 59 1.671 < 0.001 < 0.001 Co-occurrence
MUC12 MUC17 580 0 137 11 > 3 < 0.001 < 0.001 Co-occurrence
MUC16 MUC17 368 212 57 91 1.471 < 0.001 < 0.001 Co-occurrence
MUC2 MUC17 542 38 127 21 1.238 0.003 0.032 Co-occurrence
MUC5B MUC17 521 59 118 30 1.167 0.001 0.013 Co-occurrence
MUC3A MUC20 687 19 18 4 > 3 0.004 0.035 Co-occurrence
MUC4 MUC20 663 43 1 21 > 3 < 0.001 < 0.001 Co-occurrence
MUC21 MUC22 712 10 0 6 > 3 < 0.001 < 0.001 Co-occurrence
MUC2 MUC5B 599 40 70 19 2.023 < 0.001 < 0.001 Co-occurrence
MUC5B MUC6 620 79 19 10 2.046 0.001 0.014 Co-occurrence
MUC3A MUC7 681 14 24 9 > 3 < 0.001 < 0.001 Co-occurrence
LUSC MUC4 MUC20 306 18 5 140 > 3 < 0.001 < 0.001 Co-occurrence
MUC12 MUC17 373 0 76 20 > 3 < 0.001 < 0.001 Co-occurrence
MUC21 MUC22 456 9 0 4 > 3 < 0.001 < 0.001 Co-occurrence